SRI and neoplasm: As a calcium-binding protein, Sorcin is involved in tumor progression and maintenance of tumor multidrug resistance phenotypes by altering intracellular Ca2+ concentration, affecting signaling transduction, and altering the activity and function of other Ca2+-regulated proteins [6–8].